You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial

Citation Tools

Article menu

This article has a correction. Please see:

XML
Cardiovascular and metabolic risk
Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ueki K, Sasako T, Kato M, et al
Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
BMJ Open Diabetes Research and Care 2016;4:e000123. doi: 10.1136/bmjdrc-2015-000123